CAV1 and Miyoshi myopathy: Despite surviving the disturbance of redox homeostasis, these CAV1‐deficient MM cells were more sensitive to autophagy induction, glutamine depletion, and glutamine transporter inhibition, which partly explains their reduced growth and increased sensitivity to bortezomib in vivo.